Skip to main content
SpringerLink
Log in

Association between metabolic effects and tobacco use in 60-year-old Swedish men

  • DIABETES MELLITUS
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

There is a controversy whether use of smokeless tobacco is associated with an increased risk of diabetes. A population-based cross-sectional study was undertaken of 1,859 men, aged 60 years, in Stockholm County. No significant association was found between risk of diabetes and any use of tobacco, even if an association between snuff and risk of diabetes could not be excluded.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case–control study. Lancet. 2006;368:647–58. doi:10.1016/S0140-6736(06)69249-0.

    Article  PubMed  Google Scholar 

  2. Lee PN. Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. Int J Epidemiol. 2007;36:789–804. doi:10.1093/ije/dym039.

    Article  PubMed  Google Scholar 

  3. Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology. 2005;16:12–6. doi:10.1097/01.ede.0000147108.92895.ba.

    Article  PubMed  Google Scholar 

  4. Johansson SE, Sundquist K, Qvist J, Sundquist J. Smokeless tobacco and coronary heart disease: a 12-year follow-up study. Eur J Cardiovasc Prev Rehabil. 2005;12:387–92. doi:10.1097/01.hjr.0000169189.22302.99.

    Article  PubMed  Google Scholar 

  5. Haglund B, Eliasson M, Stenbeck M, Rosen M. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand J Public Health. 2007;35:618–22. doi:10.1080/14034940701436949.

    Article  Google Scholar 

  6. Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med. 2007;262:351–9. doi:10.1111/j.1365-2796.2007.01816.x.

    Article  PubMed  Google Scholar 

  7. Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson JH. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med. 2007;262:360–7. doi:10.1111/j.1365-2796.2007.01813.x.

    Article  PubMed  CAS  Google Scholar 

  8. Asplund K, Nasic S, Janlert U, Stegmayr B. Smokeless tobacco as a possible risk factor for stroke in men: a nested case–control study. Stroke. 2003;34:1754–9. doi:10.1161/01.STR.0000076011.02935.A1.

    Article  PubMed  Google Scholar 

  9. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes. Asystematic review and meta-analysis. J Am Med Assoc. 2007;298:2654–64. doi:10.1001/jama.298.22.2654.

    Article  CAS  Google Scholar 

  10. Pisinger C, Jorgensen T. Waist circumference and weight following smoking cessation in a general population: the Inter99 study. Prev Med. 2007;44:290–5. doi:10.1016/j.ypmed.2006.11.015.

    Article  PubMed  Google Scholar 

  11. Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;24:1590–5. doi:10.2337/diacare.24.9.1590.

    Article  PubMed  CAS  Google Scholar 

  12. Eliasson M, Asplund K, Nasic S, Rodu B. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. J Intern Med. 2004;256:101–10. doi:10.1111/j.1365-2796.2004.01344.x.

    Article  PubMed  CAS  Google Scholar 

  13. Norberg M, Stenlund H, Lindahl B, Boman K, Weinehall L. Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep’s clothing? Scand J Public Health. 2006;34:576–83. doi:10.1080/14034940600665143.

    Article  PubMed  Google Scholar 

  14. Persson PG, Carlsson S, Svanstrom L, Ostenson CG, Efendic S, Grill V. Cigarette smoking, oral moist snuff use and glucose intolerance. J Intern Med. 2000;248:103–10. doi:10.1046/j.1365-2796.2000.00708.x.

    Article  PubMed  CAS  Google Scholar 

  15. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52. doi:10.1161/CIRCULATIONAHA.105.169404.

    Article  PubMed  Google Scholar 

  16. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442–3. doi:10.1046/j.1464-5491.1999.00059.x.

    Article  PubMed  CAS  Google Scholar 

  17. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–62. doi:10.1016/S0140-6736(05) 67402-8.

    Article  PubMed  Google Scholar 

  18. Wandell PE, de Faire U, Hellenius ML. High intake of alcohol is associated with newly diagnosed diabetes in 60 years old men and women. Nutr Metab Cardiovasc Dis. 2007;17:598–608. doi:10.1016/j.numecd.2006.05.005.

    Article  PubMed  CAS  Google Scholar 

  19. Holm H, Jarvis MJ, Russell MA, Feyerabend C. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl). 1992;108:507–11. doi:10.1007/BF02247429.

    Article  CAS  Google Scholar 

  20. Baron JA, Comi RJ, Cryns V, Brinck-Johnsen T, Mercer NG. The effect of cigarette smoking on adrenal cortical hormones. J Pharmacol Exp Ther. 1995;272:151–5.

    PubMed  CAS  Google Scholar 

  21. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997;29:1422–31. doi:10.1016/S0735-1097(97) 00079-X.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The study was supported by grants from the Stockholm County Council, the Swedish Heart and Lung Foundation, the Swedish Council for Working Life and Social Research, the Swedish Research Council (Longitudinal Research), AstraZeneca, Pfizer, and Unilever.

Author information

Authors and Affiliations

  1. Center for Family and Community Medicine, Karolinska Institutet, Huddinge, Sweden

    Per Eric Wändell

  2. Department of Medicine, Karolinska University Hospital, 171 76, Stockholm, Sweden

    Gunilla Bolinder & Mai-Lis Hellénius

  3. Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Box 210, 171 77, Stockholm, Sweden

    Ulf de Faire

  4. Cardiovascular Laboratory, Department of Cardiology, Karolinska University Hospital, Solna, 171 76, Stockholm, Sweden

    Ulf de Faire

Authors
  1. Per Eric Wändell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gunilla Bolinder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulf de Faire
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mai-Lis Hellénius
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Per Eric Wändell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wändell, P.E., Bolinder, G., de Faire, U. et al. Association between metabolic effects and tobacco use in 60-year-old Swedish men. Eur J Epidemiol 23, 431–434 (2008). https://doi.org/10.1007/s10654-008-9260-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-008-9260-4

Keywords

Search

Navigation